Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Inbal Barnes"'
Autor:
Ayala Hubert, Tamar Hamburger, Zohar Levi, Dan Aderka, Luna Kadouri, Baruch Brenner, Ofer Margalit, Naama Halpern, Irit Ben-Aharon, Ben Boursi, Yael Laitman, Eitan Friedman, Einat Shacham-Shmueli, Tamar Peretz, Yael Goldberg, Albert Grinshpun, Inbal Barnes-Kedar, Talia Golan
Publikováno v:
OncoTargets and Therapy. 13:11637-11644
Background The prognosis of gastric cancer (GC) is poor with a median overall survival (OS) of less than 12 months in advanced-stage disease. The search for distinct genetic subgroups of GC patients and predictive biomarkers is ongoing. While BRCA1 o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e31b9b9f17ea8da508d78b1b4dcad55
https://doi.org/10.2147/ott.s276814
https://doi.org/10.2147/ott.s276814
Autor:
Naama, Halpern, Albert, Grinshpun, Ben, Boursi, Talia, Golan, Ofer, Margalit, Dan, Aderka, Eitan, Friedman, Yael, Laitman, Ayala, Hubert, Luna, Kadouri, Tamar, Hamburger, Inbal, Barnes-Kedar, Zohar, Levi, Irit, Ben-Aharon, Baruch, Brenner, Yael, Goldberg, Tamar, Peretz, Einat, Shacham-Shmueli
Publikováno v:
OncoTargets and therapy
Background The prognosis of gastric cancer (GC) is poor with a median overall survival (OS) of less than 12 months in advanced-stage disease. The search for distinct genetic subgroups of GC patients and predictive biomarkers is ongoing. While BRCA1 o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1aad9218c3a26fc1160ad08d2bb97722
https://pubmed.ncbi.nlm.nih.gov/33235458
https://pubmed.ncbi.nlm.nih.gov/33235458
Autor:
Tamar Shapira, Inbal Barnes-Kedar, Nava Ginzach, Tamar Peretz, Shulamit Hartmajer, Eitan Friedman, Yael Goldberg, Nurit Magal, Marina Lifshitc Kalis, Lina Basel-Salmon, Lily Bazak, Mordechai Shohat, Rinat Bernstein-Molho
Publikováno v:
Breast Cancer Research and Treatment. 172:151-157
BRCA1 and BRCA2 genotyping results have clinical implications for cancer risk assessment and targeted therapy. Current practice in Israel is to genotype for the predominant BRCA1/2 mutations first, followed by full gene analysis in eligible mutation-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::345c118a2cdd8bf5061cc6c24b27b17a
https://doi.org/10.1007/s10549-018-4887-7
https://doi.org/10.1007/s10549-018-4887-7
Autor:
Mark Ludman, Rinat Yerushalmi, Tamar Peretz, Nurit Magal, Avital Eilat, Inbal Barnes-Kedar, Chana Vinkler, Marina Lifshitc Kalis, Lily Bazak, Sari Liberman, Gili Reznik, Rinat Bernstein-Molho, Lina Basel-Salmon, Lilach Peled Peretz, Tamar Shapira, Ephrat Levy-Lahad, Mordechai Shohat, Hagit Baris Feldman, Eitan Friedman, Yael Goldberg, Nadra Samra
Publikováno v:
Breast cancer research and treatment. 178(1)
While the spectrum of germline mutations in BRCA1/2 genes in the Israeli Jewish population has been extensively studied, there is a paucity of data pertaining to Israeli Arab high-risk cases. Consecutive Israeli Arab breast and/or ovarian cancer pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8dd58e9a03b800b1064c9365635daa
https://pubmed.ncbi.nlm.nih.gov/31368036
https://pubmed.ncbi.nlm.nih.gov/31368036
Autor:
Israela Lerer, Marisa Halpern, Nurit Magal, Hagit N. Baris, Valerie Drasinover, Zohar Levi, Katharina Wimmer, Shlomi Cohen, Inbal Barnes-Kedar, Dov Hershkovitz, Helen Toledano, Tamar Peretz, Dani Bercovich, Elizabeth E. Half, Revital Kariv, Alexander Lossos, Yael Goldberg
Publikováno v:
Pediatric Blood & Cancer. 63:418-427
Background Heterozygous germline mutations in any of the mismatch repair (MMR) genes, MLH1, MSH2, MSH6, and PMS2, cause Lynch syndrome (LS), an autosomal dominant cancer predisposition syndrome conferring a high risk of colorectal, endometrial, and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bff51a26804571281aefbda4f92ca6fe
https://doi.org/10.1002/pbc.25818
https://doi.org/10.1002/pbc.25818
Autor:
Zohar Levi, Revital Kariv, Irit Solar, Tamar Peretz, Naama Halpern, Guy Rosner, Yael Goldberg, Hanoch Goldshmidt, Luna Kadouri, Hagit N. Baris, M. Plesser, Israela Lerer, Inbal Barnes-Kedar, Ayala Hubert, Hana Strul
Publikováno v:
Clinical Genetics. 87:549-553
Diagnosis of Lynch syndrome (LS) may be complex. Knowledge of mutation spectrum and founder mutations in specific populations facilitates the diagnostic process. Aim of the study is to describe genetic features of LS in the Israeli population and rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff39ea2be105a4ccc79710e65abc236a
https://doi.org/10.1111/cge.12530
https://doi.org/10.1111/cge.12530
Autor:
Yaron Niv, Inbal Barnes-Kedar, B. Eli, Alexander Vilkin, Hagit N. Baris, R. Elhasid, Rina Dvir, Shlomi Cohen, Naim Abu-Freha, Elizabeth E. Half, Rachel Gingold Belfer, Revital Kariv, S. Morgentern, Yael Goldberg, Zohar Levi
Publikováno v:
Clinical Genetics. 88:474-478
Data on the clinical presentation of constitutional mismatch repair deficiency syndrome (CMMRD) is accumulating. However, as the extraintestinal manifestations are often fatal and occur at early age, data on the systematic evaluation of the gastroint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b05df6a83a111bf695aa9199296f5393
https://doi.org/10.1111/cge.12518
https://doi.org/10.1111/cge.12518
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of child neurology. 31(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b7d764740197e43bdfef0ff2d78452
https://pubmed.ncbi.nlm.nih.gov/26459515
https://pubmed.ncbi.nlm.nih.gov/26459515
Autor:
Yulia Kaplan, Lior H. Katz, Yuval Yaron, Orit Reish, Lior Soussan Gutman, Rachel Michaelson-Cohen, Shani Paluch-Shimon, Valeriya Semenisty, Addie Dvir, Inbal Barnes-Kedar, Noa Efrat, Tamar Yablonski-Peretz, Tamar Safra, Eitan Friedman, Victoria Neiman, Talia Golan, Ayala Hubert, Yafit Glasser, Luna Kadouri, Bella Kaufman
Publikováno v:
Breast cancer research and treatment. 155(1)
We evaluated the clinical utility of screening for mutations in 34 breast/ovarian cancer susceptibility genes in high-risk families in Israel. Participants were recruited from 12, 2012 to 6, 2015 from 8 medical centers. All participants had high brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe0c0b3fb90641809f6e2cbe219eade
https://pubmed.ncbi.nlm.nih.gov/26687385
https://pubmed.ncbi.nlm.nih.gov/26687385